Find similar products:
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PL 00156/0322.
Clobazam Martindale Pharma 5mg/5ml and 10mg/5ml Oral Suspension
Clobazam Martindale Pharma 5mg/5ml and 10mg/5ml Oral Suspension
Clobazam
This medicine contains clobazam, which can cause dependence, tolerance and addiction. You can get withdrawal symptoms if you stop taking it or reduce the dose suddenly.
1. What Clobazam Oral Suspension is and what it is used for
2. What you need to know before you take Clobazam Oral Suspension
3. How to take Clobazam Oral Suspension
4. Possible side effects
5. How to store Clobazam Oral Suspension
6. Contents of the pack and other information
This medicine has been prescribed for you for
It contains Clobazam which belongs to a class of medicines called benzodiazepines.
This medicine has been prescribed to you and should not be given to anyone else.
Benzodiazepines can cause dependence, tolerance and addiction, and you may get withdrawal symptoms if you stop taking it or reduce the dose suddenly. Your prescriber should have explained how long you will be taking it for and, when it is appropriate to stop, how to do this safely. When your treatment is stopped, it is usually done gradually over a period which is specific to you and may occur over a period of weeks to months.
This medicine has been prescribed to you and should not be given to anyone else.
Benzodiazepines can cause dependence, tolerance and addiction, and you may get withdrawal symptoms if you stop taking it or reduce the dose suddenly. Your prescriber should have explained how long you will be taking it for and, when it is appropriate to stop, how to do this safely. When your treatment is stopped, it is usually done gradually over a period which is specific to you and may occur over a period of weeks to months.
Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue.
Switching from tablet to oral suspension
You should be careful whilst switching from tablet to oral suspension as the doses are not identical.
You might observe breathing problem or feel sleepy when switching to Clobazam oral suspension from tablet.
You might also observe an increase in frequency of epilepsy or new forms of epilepsy with Clobazam oral suspension. Please talk to your doctor if you experience this symptom.
Talk to your doctor, pharmacist or nurse before taking Clobazam Oral Suspension:
Talk to your prescriber before taking this medicine if you:
Taking this medicine regularly, particularly for a long time, can lead to physical dependence and addiction. Your prescriber should have explained how long you will be taking it for and, when it is appropriate to stop, how to do this safely. When your treatment is stopped, it is usually done gradually over a period which is specific to you and may occur over a period of weeks to months.
Physical dependence and addiction can cause withdrawal symptoms when you stop taking this medicine. Withdrawal symptoms can include:
Your prescriber will discuss with you how to gradually reduce your dose before stopping the medicine. It is important that you do not stop taking the medicine suddenly as you will be more likely to experience withdrawal symptoms. Your prescriber will ensure that your plan for stopping treatment is tailored to you and can be adapted according to your needs and experience of any withdrawal symptoms.
Benzodiazepines should only be used by those they are prescribed for. Do not give your medicine to anyone else. Taking higher doses or more frequent doses of benzodiazepines, may increase the risk of addiction. Overuse and misuse can lead to overdose and/or death.
Some patients have experienced suicidal thoughts while taking medicines containing clobazam, particularly if they are already depressed. If you start experiencing thoughts of suicide or harm towards yourself please tell your doctor immediately.
It is possible for you to become dependent on Clobazam Oral Suspension if you take it for long periods of time, particularly if you have a history of heavy alcohol or drug use. This means that you may feel that you need to continue treatment with Clobazam Oral Suspension in order to feel well (known as psychological dependence). If you suddenly stop taking Clobazam Oral Suspension you may experience worsening of the symptoms you were originally being treated for, as well as mood changes, anxiety, sleep disturbance or restlessness.
This is known as withdrawal and can be avoided by slowly reducing your dose. If you are worried about dependence or withdrawal please talk to your doctor.
If you take Clobazam Oral Suspension for long periods of time for treatment of epilepsy it is possible that you may become tolerant to it, meaning that it will not be as effective as it was when you first started taking it. If you feel that Clobazam Oral Suspension is no longer helping to control your symptoms please talk to your doctor, they may suggest you take a short break from this medicine.
Clobazam oral suspension should only be used in children from 6 months to 2 years old, under exceptional situations, where there is a clear epilepsy indication.
Drowsiness, difficulties breathing, coma and death may occur if Clobazam oral suspension is taken together with opioids. Clobazam oral suspension and opioids should only be used concomitantly, when other treatment options are inadequate.
Please tell your doctor about all opioid medicines you are taking and follow your doctor’s dosage recommendations closely.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription including herbal medicines.
Also, some medicines can affect the way Clobazam works. Especially:
Concomitant use of Clobazam and opioids (strong pain killers, medicines for substitution therapy and some cough medicines) increases the risk of drowsiness, difficulties in breathing (respiratory depression), coma and may be life-threatening.
Because of this, concomitant use should only be considered when other treatment options are not possible.
However if your doctor does prescribe Clobazam together with opioids the dose and duration of concomitant treatment should be limited by your doctor.
Please tell your doctor about all opioid medicines you are taking, and follow your doctor’s dose recommendation closely. It could be helpful to inform friends or relatives to be aware of the signs and symptoms stated above. Contact your doctor when experiencing such symptoms.
If you are not sure if any of the above apply to you talk to your doctor or pharmacist.
If you are going to have an anaesthetic, tell your doctor or anaesthetist you are taking Clobazam Oral Suspension. This is because your doctor may need to change the amount of anaesthetic or muscle relaxants given to you.
Do not drink alcohol while you are taking Clobazam Oral Suspension. This is because there is increased risk of sleepiness and other side effects.
Pregnancy
Use of this medicine is not recommended during pregnancy and in women of childbearing potential not using contraception.
If you discover that you are pregnant or are planning to have a baby, consult your doctor right away to re-assess the need for treatment. Do not stop taking Clobazam without talking to your doctor.
A large amount of data has not shown evidence of malformations associated with the use of benzodiazepines. However, some studies have shown a potentially increased risk of cleft lip and palate in newborn babies compared to that in the general population.
Cleft lip and palate (sometimes called “harelip”) is a deformation at birth caused by incomplete fusion of the palate and upper lip.
Reduced fetal movement and fetal heart rate variability may occur after taking Clobazam during the second and/or third trimester of pregnancy.
If Clobazam is taken at the end of pregnancy or during childbirth, your baby may show drowsiness (sedation), muscle weakness (hypotonia or floppy infant syndrome), a drop in body temperature (hypothermia), difficulty feeding (problems suckling causing poor weight gain) and breathing problems (respiratory depression sometimes severe).
If taken regularly in late pregnancy, your baby may get withdrawal symptoms such as agitation or shaking. In this case the newborn should be closely monitored during the postnatal period.
You may feel sleepy or have concentration or memory problems after taking this medicine. You may also experience double vision or you may react more slowly to things. If this happens, do not drive or use any tools or machines.
The medicine can affect your ability to drive as it may make you sleepy or dizzy.
Talk to your doctor or pharmacist if you are not sure whether it is safe for you to drive while taking this medicine.
The signs may include a rash, swallowing or breathing problems and swelling of your lips, face, throat or tongue
If you have any concerns over whether this medicine is suitable for you talk to your doctor, pharmacist or nurse.
Always take this medicine exactly as your doctor or pharmacist has told you. Clobazam Oral Suspension is usually given for 2 to 4 weeks. Your prescriber should have discussed with you how long the course of the oral solution will last. They will arrange a plan for stopping treatment. This will outline how to gradually reduce the dose and stop taking the medicine. Your prescriber will ensure that your plan for stopping treatment is tailored to you and can be adapted according to your needs and experience of any withdrawal symptoms.
When you are taking Clobazam Oral Suspension you should not change to any different Clobazam containing medicines except under your doctor’s supervision.
Adults (Anxiety and Epilepsy)
The usual dose is 20mg (20ml) to 30mg (30ml) each day. This can be taken as two separate doses or as a single dose at night.
Use in children (over 2 years) (Epilepsy)
Use in children (6 month-2 years) (Epilepsy)
Elderly (Anxiety)
Adults (Anxiety and Epilepsy)
The usual dose is 20mg (10ml) to 30mg (15ml) each day. This can be taken as two separate doses or as a single dose at night.
Use in children (over 2 years) (Epilepsy)
Use in children (6 month-2 years) (Epilepsy)
Elderly (Anxiety)
This product may settle during storage. Please shake well before use.
Your doctor, pharmacist or nurse will show you how to administer this medicine. The box containing this medicine will contain a 5ml dosing syringe, a dosing adaptor and a 30ml dosing cup.
1ml syringe is provided only with the 150ml pack size of Clobazam 5mg/5ml Oral Suspension and is for patients who require small doses of less than 1ml.
1ml syringe each numbered increment is 0.1ml equivalent to 0.1mg Clobazam 5mg/5ml Oral Suspension. The intermediate increments are 0.05ml equivalent to 0.05mg Clobazam 5mg/5ml Oral Suspension. The smaller increments are 0.01ml equivalent to 0.01mg Clobazam 5mg/5ml Oral Suspension.
5ml syringe each numbered increment is 1ml equivalent to 1mg of Clobazam 5mg/5ml Oral Suspension and 2mg of Clobazam 10mg/5ml Oral Suspension. The smaller increments are 0.2ml or 0.2mg of Clobazam 5mg/5ml Oral Suspension and 0.4mg of Clobazam 10mg/5ml Oral Suspension.
30ml dosing cup. Each numbered increment is 5ml - equivalent to 5mg of Clobazam 5mg/5ml Oral Suspension and 10mg of Clobazam 10mg/5ml Oral Suspension.
Instructions are provided overleaf for using the dosing syringe. If you have any questions about the dose you should use or how to use the syringe, you should ask your pharmacist.
Open the bottle: press the cap and turn it anticlockwise (figure 1)
Holding the bottle, take the plastic syringe adaptor from the box and insert the adaptor into the bottle neck (figure 2). Ensure it is well fixed.
Take the syringe and put it in the adaptor opening (figure 3). Turn the bottle upside down.
Fill the syringe with a small amount of suspension by pulling the piston down (figure 4a), then push the piston upward in order to remove any possible bubble (figure 4b). Pull the piston down to the graduation mark corresponding to the quantity in milliliters (ml) prescribed by your doctor (figure 4C).
Turn the bottle the right way up.
Remove the syringe from the adaptor (figure 5)
Administer the contents of the syringe into the mouth by pushing the piston to the bottom of the syringe (figure 6) and ensure the medicine is swallowed.
Remove the adaptor from the bottle and close the bottle with the plastic screw cap.
Wash the adaptor and the syringe with warm water.
Dry them with a clean paper towel and replace them into the box with your medicine.
If you take more Clobazam Oral Suspension than you should, tell your doctor or go to your nearest hospital casualty department immediately. Do not drive yourself because you may start to feel sleepy.
If you have missed a dose take it as soon as you remember unless it is almost time for the next one then carry on as before. Do not take a double dose to make up for a forgotten dose.
Do not suddenly stop taking this medicine. If you want to stop taking this medicine, discuss this with your prescriber first. They will tell you how to do this, usually by reducing the dose gradually so that any unpleasant withdrawal effects are kept to a minimum. This may occur over a period of weeks to months. Your prescriber will ensure that your plan for stopping treatment is tailored to you and can be adapted according to your needs and experience of any withdrawal symptoms.
Withdrawal symptoms such as:
(see Section 2 ‘Dependence, tolerance and withdrawal’).
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious Side Effects:
Tell your doctor immediately if you have any of the following side effects.
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Not Known (frequency cannot be estimated from the available data):
Tell your doctor or pharmacist if any of the following side effects get serious or lasts longer than a few days, or if you notice any side effects not listed in this leaflet.
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Not known (frequency cannot be estimated from available data):
The following side effects are more likely to happen at the start of treatment. They usually last for a short time: feeling tired, dry mouth, constipation, loss of appetite, feeling sick, shaking fingers.
If you take this medicine for a long time, you are more likely to get the following side effects:
anxiety, confusion, depression, loss of appetite and difficulty sleeping.
When you stop taking Clobazam oral suspension, you may experience drug withdrawal symptoms, which include:
How do I know if I am tolerant or addicted?
If you notice any of the following signs whilst taking Clobazam oral suspension, it could be a sign that you have become addicted.
If you notice any of these signs, it is important you talk to your prescriber.
If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: http://www.mhra.gov.uk/yellowcard in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use Clobazam Oral Suspension after the expiry date stated on the bottle label and carton after EXP. The expiry date refers to the last day of that month.
Do not store above 25ºC. Use within 28 days of opening. Keep the bottle in the outer carton.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
Clobazam Oral Suspension is an off-white viscous suspension with an odour of raspberry supplied in an amber glass bottle.
The contents may settle during storage and should be shaken before use.
Pack sizes are 100ml, 150ml and 250ml.
If you would like any more information, or would like the leaflet in a different format, please contact medical information at the above address.
Product licence numbers: PL 00156/0322
PL 00156/0323
This leaflet was last revised in November 2025.
D0654800000